Jan Asad, Gokce Ozgun, Luthi-Carter Ruth, Lashuel Hilal A
Laboratory of Molecular Neurobiology and Neuroproteomics, Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.
J Biol Chem. 2008 Oct 17;283(42):28176-89. doi: 10.1074/jbc.M803159200. Epub 2008 Aug 11.
Aggregation and fibril formation of amyloid-beta (Abeta) peptides Abeta40 and Abeta42 are central events in the pathogenesis of Alzheimer disease. Previous studies have established the ratio of Abeta40 to Abeta42 as an important factor in determining the fibrillogenesis, toxicity, and pathological distribution of Abeta. To better understand the molecular basis underlying the pathologic consequences associated with alterations in the ratio of Abeta40 to Abeta42, we probed the concentration- and ratio-dependent interactions between well defined states of the two peptides at different stages of aggregation along the amyloid formation pathway. We report that monomeric Abeta40 alters the kinetic stability, solubility, and morphological properties of Abeta42 aggregates and prevents their conversion into mature fibrils. Abeta40, at approximately equimolar ratios (Abeta40/Abeta42 approximately 0.5-1), inhibits (> 50%) fibril formation by monomeric Abeta42, whereas inhibition of protofibrillar Abeta42 fibrillogenesis is achieved at lower, substoichiometric ratios (Abeta40/Abeta42 approximately 0.1). The inhibitory effect of Abeta40 on Abeta42 fibrillogenesis is reversed by the introduction of excess Abeta42 monomer. Additionally, monomeric Abeta42 and Abeta40 are constantly recycled and compete for binding to the ends of protofibrillar and fibrillar Abeta aggregates. Whereas the fibrillogenesis of both monomeric species can be seeded by fibrils composed of either peptide, Abeta42 protofibrils selectively seed the fibrillogenesis of monomeric Abeta42 but not monomeric Abeta40. Finally, we also show that the amyloidogenic propensities of different individual and mixed Abeta species correlates with their relative neuronal toxicities. These findings, which highlight specific points in the amyloid peptide equilibrium that are highly sensitive to the ratio of Abeta40 to Abeta42, carry important implications for the pathogenesis and current therapeutic strategies of Alzheimer disease.
淀粉样β蛋白(Aβ)肽Aβ40和Aβ42的聚集和纤维形成是阿尔茨海默病发病机制中的核心事件。先前的研究已确定Aβ40与Aβ42的比例是决定Aβ的纤维形成、毒性和病理分布的一个重要因素。为了更好地理解与Aβ40与Aβ42比例改变相关的病理后果的分子基础,我们探究了这两种肽在淀粉样形成途径中不同聚集阶段的明确状态之间的浓度和比例依赖性相互作用。我们报告称,单体Aβ40改变了Aβ42聚集体的动力学稳定性、溶解度和形态特性,并阻止其转化为成熟纤维。Aβ40以大约等摩尔比(Aβ40/Aβ42约为0.5 - 1)抑制(>50%)单体Aβ42的纤维形成,而以较低的亚化学计量比(Aβ40/Aβ42约为0.1)可抑制原纤维状Aβ42的纤维形成。通过引入过量的Aβ42单体可逆转Aβ40对Aβ42纤维形成的抑制作用。此外,单体Aβ42和Aβ40不断循环,并竞争结合到原纤维状和纤维状Aβ聚集体的末端。虽然两种单体物种的纤维形成都可以由由任何一种肽组成的纤维引发,但Aβ42原纤维选择性地引发单体Aβ42而非单体Aβ40的纤维形成。最后,我们还表明,不同个体和混合Aβ物种的淀粉样生成倾向与其相对神经元毒性相关。这些发现突出了淀粉样肽平衡中对Aβ40与Aβ42比例高度敏感的特定点,对阿尔茨海默病的发病机制和当前治疗策略具有重要意义。